Literature DB >> 96470

Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.

G Anlezark, B Meldrum.   

Abstract

The effect of the intravenous administration of ergot alkaloids on epileptic responses to intermittent photic stimulation )IPS) has been studied in adolescent baboons, Papio papio, from Senegal. Ergocornine, 1--2 mg/kg, produced marked autonomic and behavioural effects, slowed the EEG, and abolished myoclonic responses to IPS for 30--90 min. Ergometrine, 1 mg/kg, activated the EEG and blocked the induction of myoclonic responses for 1--3 h. Bromocriptine, 0.5--4 mg/kg, did not consistently prevent myoclonic responses to IPS. After pretreatment with a subconvulsant dose of allylglycine (180--200 mg/kg), lysergic acid diethylamide, 0.1 mg/kg, retained the capacity to block myoclonic responses to IPS, and ergocornine 1 mg/kg reduced such responses. The convulsant effect of allylglycine was enhanced, however, so that prolonged seizure sequences began 19--96 min after ergocornine administration. The protective action of ergot alkaloids against epileptic responses induced by sensory stimulation is interpreted in terms of effects at several sites, including dopaminergic and serotoninergic synapses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96470     DOI: 10.1007/bf00426958

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Rotational behavior induced in rats by intranigral picrotoxin.

Authors:  D Tarsy; C Pycock; B Meldrum; C D Marsden
Journal:  Brain Res       Date:  1975-05-16       Impact factor: 3.252

2.  Effects of bromocriptine on central dopaminergic receptors.

Authors:  M Trabucchi; P F Spano; G C Tonon; L Frattola
Journal:  Life Sci       Date:  1976-07-15       Impact factor: 5.037

3.  Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

4.  Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

Authors:  A M Johnson; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

Review 5.  LSD and CNS transmission.

Authors:  G K Aghajanian
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

6.  LSD as an agonist and antagonist at central dopamine receptors.

Authors:  K Von Hungen; S Roberts; D F Hill
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

7.  Inhibition of reflex epilepsy by (+/-)-N-n-propylnorapomorphine.

Authors:  C Ashton; G Anlezark; B Meldrum
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432

8.  Ergot alkaloids as dopamine agonists: comparison in two rodent models.

Authors:  G Anlezark; C Pycock; B Meldrum
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432

9.  Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio).

Authors:  B S Meldrum; R Naquet
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1971-12

10.  Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.

Authors:  R W Horton; B S Meldrum
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

View more
  3 in total

1.  Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy.

Authors:  G M Anlezark; D H Blackwood; B S Meldrum; V J Ram; J L Neumeyer
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  Increased paroxysmal activity of partial seizures in man by apomorphine.

Authors:  M Del Zompo; F Tocco; F Marrosu; N Passino; G U Corsini
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 3.  Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update.

Authors:  Parina Asgharian; Cristina Quispe; Jesús Herrera-Bravo; Mahsa Sabernavaei; Kamran Hosseini; Haleh Forouhandeh; Tahereh Ebrahimi; Paria Sharafi-Badr; Vahideh Tarhriz; Saiedeh Razi Soofiyani; Paweł Helon; Jovana Rajkovic; Sevgi Durna Daştan; Anca Oana Docea; Javad Sharifi-Rad; Daniela Calina; Wojciech Koch; William C Cho
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.